TOPSTANDARDCORP(08510.HK)擬配售最多1.6億股告吹
格隆匯5月6日丨TOPSTANDARDCORP(08510.HK)公佈,有關根據一般授權配售最多1.60億股新股份,根據配售協議及該等公告,倘配售事項的任何條件於2020年5月6日或之前仍未達成,則配售事項將不會進行,且配售協議以及配售代理及公司於配售協議項下的所有權利及義務將告失效及終止。於公告日期,由於載於配售協議的部分條件仍未達成,因此配售協議已告失效。
由於配售協議失效,董事將繼續評估在資本市場籌集資金的其他方式以滿足上述需求,而公司將於適當時間及/或根據GEM上市規則之要求作出進一步公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.